Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
5
63%
Ph phase_2
3
38%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(2)
Other(5)

Detailed Status

unknown5
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (37.5%)
Phase 35 (62.5%)

Trials by Status

unknown563%
completed225%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_3

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

NCT06017583
unknownphase_2

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

NCT04062058
unknownphase_3

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

NCT04500145
unknownphase_3

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

NCT01817023
completedphase_2

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

NCT02979691
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06017583Phase 3

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Recruiting
NCT04062058Phase 2

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Unknown
NCT04500145Phase 3

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

Unknown
NCT01817023Phase 3

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Unknown
NCT02979691Phase 2

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Completed
NCT02301481Phase 2

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Completed
NCT03308552Phase 3

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Unknown
NCT03328234Phase 3

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

Unknown

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8